STOCK TITAN

Planet 13 Holdings Inc. Announces Closing of C$28.8 Million Bought Deal Public Offering

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Planet 13 Holdings has successfully completed a bought deal financing, raising C$28,804,625 by selling 6,698,750 units at C$4.30 each. The offering included an over-allotment option of 873,750 units. Each unit consists of one common share and a warrant for an additional share at C$5.80 for 24 months. The funds are earmarked for retail expansion outside Nevada and general corporate needs. The offering was co-led by Canaccord Genuity Corp. and Beacon Securities Limited.

Positive
  • Raised C$28,804,625 for expansion and working capital.
  • Successful execution of bought deal financing.
  • Inclusion of additional over-allotment option.
Negative
  • Potential dilution of existing shares due to new unit offerings.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

LAS VEGAS, NV / ACCESSWIRE / November 5, 2020 / Planet 13 Holdings Inc. ("Planet 13" or the "Company") (CSE:PLTH)(OTCQB:PLNHF) is pleased to announce that it has completed its previously-announced bought deal financing for aggregate gross proceeds of C$28,804,625 (the "Offering").

A total of 6,698,750 units (the "Units") of the Company were sold pursuant to the Offering, including an aggregate of 873,750 Units issued as a result of the full exercise of the over-allotment option (the "Over-Allotment Option"), at a price of C$4.30 per Unit.

The Offering was co-led by Canaccord Genuity Corp. and Beacon Securities Limited (collectively, the "Underwriters").

Each Unit consists of one (1) common share (a "Common Share") in the capital of the Company and one-half (1/2) of one Common Share purchase warrant (each whole Common Share purchase warrant, a "Warrant"). Each Warrant entitles the holder thereof to acquire one Common Share at an exercise price per Common Share of C$5.80 for a period of 24 months from the closing of the Offering.

The net proceeds from the Offering will be used for retail expansion of the Company outside of Nevada, and general corporate and other working capital purposes.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws and may not be offered or sold within the United States or to U.S. persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

About Planet 13
Planet 13 (www.planet13holdings.com) is a vertically integrated cannabis company based in Nevada, with award-winning cultivation, production and dispensary operations in Las Vegas - the entertainment capital of the world. Planet 13's mission is to build a recognizable global brand known for world-class dispensary operations and a creator of innovative cannabis products. Planet 13's shares trade on the Canadian Securities Exchange (CSE) under the symbol PLTH and OTCQX under the symbol PLNHF.

Cautionary Note Regarding Forward-Looking Information
This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements.

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: final regulatory and other approvals or consents; risks associated with COVID-19 and other infectious diseases presenting as major health issues; fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the Nevada cannabis market and changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution and sale of cannabis and cannabis-related products in the State of Nevada; and employee relations. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law. The Company is indirectly involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational and medicinal cannabis marketplace in the United States through its subsidiary MM Development Company, Inc. ("MMDC"). Local state laws where MMDC operates permit such activities, however, these activities are currently illegal under United States federal law. Additional information regarding this and other risks and uncertainties relating to the Company's business, including COVID-19, are contained under the heading "Risk Factors" in the Company's annual information form dated April 13, 2020 filed on its issuer profile on SEDAR at www.sedar.com.

For further inquiries, please contact:
Robert Groesbeck or Larry Scheffler
Co-Chief Executive Officers
ir@planet13lasvegas.com

Mark Kuindersma, CFA
LodeRock Advisors Inc., Planet 13 Investor Relations
mark.kuindersma@loderockadvisors.com
416-519-2156 ext. 2230

SOURCE: Planet 13 Holdings



View source version on accesswire.com:
https://www.accesswire.com/614599/Planet-13-Holdings-Inc-Announces-Closing-of-C288-Million-Bought-Deal-Public-Offering

FAQ

What is the amount raised in the latest financing round by PLNHF?

Planet 13 Holdings raised C$28,804,625 in their latest bought deal financing.

What will the proceeds be used for by Planet 13 Holdings (PLNHF)?

The proceeds will be used for retail expansion outside of Nevada and general working capital.

How many units were sold in the PLNHF financing?

A total of 6,698,750 units were sold in the financing.

What is the exercise price of the warrants issued in the PLNHF offering?

The warrants have an exercise price of C$5.80.

Who led the underwriting for the PLNHF offering?

The offering was co-led by Canaccord Genuity Corp. and Beacon Securities Limited.

Planet 13 Holdings Inc.

OTC:PLNHF

PLNHF Rankings

PLNHF Latest News

PLNHF Stock Data

195.57M
135.45M
39.65%
0.34%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Las Vegas